This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

Traditional drug discovery is slow, costly, and often disconnected from the real biology of patients. However, biobank resources like the UK Biobank can help overcome current challenges by delivering ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...